Inclusion Criteria:

- Healthy male and female full-term (37-42 weeks gestation) neonates (birth to 10 days
of age)

- Born to mothers with documented negative test for HBsAg within 9 months prior to
delivery

Exclusion Criteria:

- Infant born to mother with no prenatal care

- Known or suspected impairment of immunologic function

- Prior vaccination with any hepatitis B vaccine for infant or mother(within 6 months
prior to the birth of infant.)

- Recent(<72 hours) history of febrile illness >/= 99.5 degrees F (>/= 37.5 degrees C)
axillary or >/= 100.5 degrees F (>/= 38.1 degrees C) rectal

- Any prior administration of hepatitis B immune globulin (HBIG), serum immune
globulin, or any other blood-derived product, or the receipt by the mother of either
immunoglobulin or HBIG within 6 months prior to birth of the infant

- Receipt of investigational vaccines by mother or infant within 3 months prior to
first injection with study vaccine or if scheduled to be given to the infant during
the study

- Known or suspected hypersensitivity to any component of study vaccine (e.g.,
aluminum, yeast)

- Any infant who cannot be adequately followed for study visits during the course of
the clinical study

- Any condition that in the opinion of the investigator, may interfere with the
evaluation of study objectives